SNPs

Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk
women.
Kontorovich T, Levy A, Korostishevsky M, Nir U, Friedman E.
Int J Cancer. 2010 Aug 1;127(3):589-97.

Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer.
Lee HC, Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Jeon SW, Lee MH, Lim KH, Park JY, Choi GS, Jun SH.
J Cancer Res Clin Oncol. 2010 Jul;136(7):1073-8.

Genetic variation in microRNA networks: the implications for cancer research.
Ryan BM, Robles AI, Harris CC.
Nat Rev Cancer. 2010 Jun;10(6):389-402.

Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X, Chen X, Hu L, Han S, Qiang F, Wu Y, Pan L, Shen H, Li Y, Hu Z.
Gynecol Oncol. 2010 May;117(2):287-90.

Genetic variation in FGF20 modulates hippocampal biology.
Lemaitre H, Mattay VS, Sambataro F, Verchinski B, Straub RE, Callicott JH, Kittappa R, Hyde TM, Lipska BK, Kleinman JE, McKay R,
Weinberger DR.
J Neurosci. 2010 Apr 28;30(17):5992-7.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G,
Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.
Cancer Res. 2010 Apr 1;70(7):2789-98.

A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo.
Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX, Wu HF.
Prostate. 2010 Apr 1;70(5):467-72.

Single nucleotide polymorphism associated with nonsyndromic cleft palate influences the processing of miR-140.
Li L, Meng T, Jia Z, Zhu G, Shi B.
Am J Med Genet A. 2010 Apr;152A(4):856-62.

Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein.
Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Landi D, Gemignani F, Landi S.
Occup Environ Med. 2010 Apr;67(4):233-6.

Short communication: genetic variability in the predicted microRNA target sites of caprine casein genes.
Zidi A, Amills M, Tomás A, Vidal O, Ramírez O, Carrizosa J, Urrutia B, Serradilla JM, Clop A.
J Dairy Sci. 2010 Apr;93(4):1749-53.

An improved in silico selection of phenotype affecting polymorphisms in SLC6A4, HTR1A and HTR2A genes.
Piva F, Giulietti M, Nardi B, Bellantuono C, Principato G.
Hum Psychopharmacol. 2010 Mar;25(2):153-61.

miRNA mutations are not a common cause of deafness.
Hildebrand MS, Witmer PD, Xu S, Newton SS, Kahrizi K, Najmabadi H, Valle D, Smith RJ.
Am J Med Genet A. 2010 Mar;152A(3):646-52.

Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human
disease.
Muiños-Gimeno M, Montfort M, Bayés M, Estivill X, Espinosa-Parrilla Y.
Eur J Hum Genet. 2010 Feb;18(2):218-26.

Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.
Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, Keating MJ, Croce CM,
Calin GA.
Carcinogenesis. 2010 Feb;31(2):208-15.

An insertion/deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with
susceptibility for hepatocellular carcinoma in Chinese.
Chen S, He Y, Ding J, Jiang Y, Jia S, Xia W, Zhao J, Lu M, Gu Z, Gao Y.
Biochem Biophys Res Commun. 2010 Jan 1;391(1):552-6.

Common genetic variants in pre-microRNAs are associated with risk of coal workers' pneumoconiosis.
Wang M, Ye Y, Qian H, Song Z, Jia X, Zhang Z, Zhou J, Ni C.
J Hum Genet. 2010 Jan;55(1):13-7.

Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.
Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P,
Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P,
Burwinkel B, Peterlongo P.
Hum Mutat. 2010 Jan;31(1):E1052-7.

Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates.
Hiard S, Charlier C, Coppieters W, Georges M, Baurain D.
Nucleic Acids Res. 2010 Jan;38(Database issue):D640-51.

MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.
Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR.
PLoS One. 2009 Dec 24;4(12):e8445.

A computation to integrate the analysis of genetic variations occurring within regulatory elements and their possible effects.
Wu LC, Horng JT, Chen YA.
J Comput Biol. 2009 Dec;16(12):1731-47.

Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle
progression/differentiation pathways in multiple common human disorders.
Glinskii AB, Ma J, Ma S, Grant D, Lim CU, Sell S, Glinsky GV.
Cell Cycle. 2009 Dec;8(23):3925-42.

An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for
hepatocellular carcinoma.
Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu Y, Guo B, Shen Y, Landi D, Landi S, Zhou Y, Liu H.
Carcinogenesis. 2009 Dec;30(12):2064-9.

Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.
Fenoglio C, Galimberti D, Cortini F, Kauwe JS, Cruchaga C, Venturelli E, Villa C, Serpente M, Scalabrini D, Mayo K, Piccio LM, Clerici F,
Albani D, Mariani C, Forloni G, Bresolin N, Goate AM, Scarpini E.
J Alzheimers Dis. 2009 Nov;18(3):603-12.

An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of
breast cancer onset.
Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K.
Clin Cancer Res. 2009 Oct 1;15(19):6292-300.

A genome-wide survey of copy number variations in Han Chinese residing in Taiwan.
Lin CH, Lin YC, Wu JY, Pan WH, Chen YT, Fann CS.
Genomics. 2009 Oct;94(4):241-6.

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, Rivas GE, Alluin J, Rossi JJ, Krontiris TG, Weitzel J, Daly MB, Benson
AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Larson GP.
Cancer Res. 2009 Sep 15;69(18):7459-65.

Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes.
Duan S, Mi S, Zhang W, Dolan ME.
RNA Biol. 2009 Sep-Oct;6(4):412-25.

SNPs in human miRNA genes affect biogenesis and function.
Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, Sommer SS, Rossi JJ.
RNA. 2009 Sep;15(9):1640-51.

APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease.
Bettens K, Brouwers N, Engelborghs S, Van Miegroet H, De Deyn PP, Theuns J, Sleegers K, Van Broeckhoven C.
Hum Mutat. 2009 Aug;30(8):1207-13.

Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population.
Xu J, Hu Z, Xu Z, Gu H, Yi L, Cao H, Chen J, Tian T, Liang J, Lin Y, Qiu W, Ma H, Shen H, Chen Y.
Hum Mutat. 2009 Aug;30(8):1231-6.

Insights into the importance of miRNA-related polymorphisms to heart disease.
Clop A.
Hum Mutat. 2009 Aug;30(8):v.

SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies.
Xu Z, Taylor JA.
Nucleic Acids Res. 2009 Jul 1;37(Web Server issue):W600-5.

Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.
Feinberg-Gorenshtein G, Avigad S, Jeison M, Halevy-Berco G, Mardoukh J, Luria D, Ash S, Steinberg R, Weizman A, Yaniv I.
Genes Chromosomes Cancer. 2009 Jul;48(7):539-43.

Genomic sequence matters: a SNP in microRNA-146a can turn anti-apoptotic.
Jazdzewski K, de la Chapelle A.
Cell Cycle. 2009 Jun 1;8(11):1642-3.

MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift.
Fabbri M, Valeri N, Calin GA.
Carcinogenesis. 2009 Jun;30(6):912-7.

A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, McClean MD, Marsit CJ, Kelsey KT.
Carcinogenesis. 2009 Jun;30(6):1003-7.

Germline mutation of microRNA-125a is associated with breast cancer.
Li W, Duan R, Kooy F, Sherman SL, Zhou W, Jin P.
J Med Genet. 2009 May;46(5):358-60.

An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice.
Lewis MA, Quint E, Glazier AM, Fuchs H, De Angelis MH, Langford C, van Dongen S, Abreu-Goodger C, Piipari M, Redshaw N, Dalmay
T, Moreno-Pelayo MA, Enright AJ, Steel KP.
Nat Genet. 2009 May;41(5):614-8.

Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss.
Mencía A, Modamio-Høybjør S, Redshaw N, Morín M, Mayo-Merino F, Olavarrieta L, Aguirre LA, del Castillo I, Steel KP, Dalmay T,
Moreno F, Moreno-Pelayo MA.
Nat Genet. 2009 May;41(5):609-13.

Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression.
Kim J, Bartel DP.
Nat Biotechnol. 2009 May;27(5):472-7.

dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation.
Hariharan M, Scaria V, Brahmachari SK.
BMC Bioinformatics. 2009 Apr 16;10:108.

Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504.
Huang W, Li MD.
Biol Psychiatry. 2009 Apr 15;65(8):702-5.

A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human
behaviors.
Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, Furneaux HM.
Mol Psychiatry. 2009 Apr;14(4):381-9.

A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.
Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H.
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1183-7.

Human genome connectivity code links disease-associated SNPs, microRNAs and pyknons.
Glinsky GV.
Cell Cycle. 2009 Mar 15;8(6):925-30.

Novel genetic variants in microRNA genes and familial breast cancer.
Shen J, Ambrosone CB, Zhao H.
Int J Cancer. 2009 Mar 1;124(5):1178-82.

Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension.
Yang Z, Kaye DM.
Hum Mutat. 2009 Mar;30(3):328-33.

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.
Mishra PJ, Bertino JR.
Pharmacogenomics. 2009 Mar;10(3):399-416.

A dominant mutation in DCL1 suppresses the hyl1 mutant phenotype by promoting the processing of miRNA.
Tagami Y, Motose H, Watanabe Y.
RNA. 2009 Mar;15(3):450-8.

Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer.
Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, de la Chapelle A.
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1502-5.

Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H.
Hum Mutat. 2009 Jan;30(1):79-84.

A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal
women.
Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Ditsch
N, Meindl A, Schmutzler RK, Bartram CR, Burwinkel B.
Carcinogenesis. 2009 Jan;30(1):59-64.

A large-scale survey of genetic copy number variations among Han Chinese residing in Taiwan.
Lin CH, Li LH, Ho SF, Chuang TP, Wu JY, Chen YT, Fann CS.
BMC Genet. 2008 Dec 24;9:92.

Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma.
Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X.
Clin Cancer Res. 2008 Dec 1;14(23):7956-62.

Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.
Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF,
Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Dickson
DW.
Hum Mol Genet. 2008 Dec 1;17(23):3631-42.

Disease phenocode analysis identifies SNP-guided microRNA maps (MirMaps) associated with human "master" disease genes.
Glinsky GV.
Cell Cycle. 2008 Dec;7(23):3680-94.

Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X.
Cancer Prev Res (Phila Pa). 2008 Nov;1(6):460-9.

A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, Yang JR, Su H, Zhuang SM.
Carcinogenesis. 2008 Nov;29(11):2126-31.

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R,
Zelterman D, Kidd KK, Zhu Y, Christiani DC, Belinsky SA, Slack FJ, Weidhaas JB.
Cancer Res. 2008 Oct 15;68(20):8535-40.

First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with
diarrhea predominant irritable bowel syndrome.
Kapeller J, Houghton LA, Mönnikes H, Walstab J, Möller D, Bönisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N,
Fischer C, Whorwell PJ, Atkinson W, Fell C, Büchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B.
Hum Mol Genet. 2008 Oct 1;17(19):2967-77.

MicroRNA target site polymorphisms and human disease.
Sethupathy P, Collins FS.
Trends Genet. 2008 Oct;24(10):489-97.

A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H.
Carcinogenesis. 2008 Oct;29(10):1963-6.

Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of
ACAA-insertion/deletion polymorphism with type 2 diabetes.
Lv K, Guo Y, Zhang Y, Wang K, Jia Y, Sun S.
Biochem Biophys Res Commun. 2008 Sep 12;374(1):101-5.

Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, L'Abbe D, Yu Z, Shen SH.
Carcinogenesis. 2008 Sep;29(9):1710-6.

An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal
components of the nuclear import pathway.
Glinsky GV.
Cell Cycle. 2008 Aug 15;7(16):2570-83.

[Identification of SNPs located in putative microRNA tar-get region of six functional genes in chickens through bioinformatic analysis]
Geng LY, Zhang CS, DU LX.
Yi Chuan. 2008 Aug;30(8):1026-32.

Functional genetic variation of human miRNAs and phenotypic consequences.
Borel C, Antonarakis SE.
Mamm Genome. 2008 Aug;19(7-8):503-9.

ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs.
Smirnov DA, Cheung VG.
Am J Hum Genet. 2008 Aug;83(2):243-53.

Genetic variants of miRNA sequences and non-small cell lung cancer survival.
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, Chen Y, Shen H.
J Clin Invest. 2008 Jul;118(7):2600-8.

Polymorphisms in microRNA targets: a gold mine for molecular epidemiology.
Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W.
Carcinogenesis. 2008 Jul;29(7):1306-11.

Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
Brendle A, Lei H, Brandt A, Johansson R, Enquist K, Henriksson R, Hemminki K, Lenner P, Försti A.
Carcinogenesis. 2008 Jul;29(7):1394-9.

Mutation of miRNA target sequences during human evolution.
Gardner PP, Vinther J.
Trends Genet. 2008 Jun;24(6):262-5.

Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma.
Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A.
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7269-74.

Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X.
Cancer Res. 2008 Apr 1;68(7):2530-7.

MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.
Mishra PJ, Mishra PJ, Banerjee D, Bertino JR.
Cell Cycle. 2008 Apr;7(7):853-8.

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian F, Landi S.
Carcinogenesis. 2008 Mar;29(3):579-84.

Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas.
Yang J, Zhou F, Xu T, Deng H, Ge YY, Zhang C, Li J, Zhuang SM.
Mutat Res. 2008 Feb 1;638(1-2):205-9.

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
Wang G, van der Walt JM, Mayhew G, Li YJ, Züchner S, Scott WK, Martin ER, Vance JM.
Am J Hum Genet. 2008 Feb;82(2):283-9.

A catalog of polymorphisms falling in microRNA-binding regions of cancer genes.
Landi D, Gemignani F, Barale R, Landi S.
DNA Cell Biol. 2008 Jan;27(1):35-43.

Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNPeffect and PupaSuite databases.
Reumers J, Conde L, Medina I, Maurer-Stroh S, Van Durme J, Dopazo J, Rousseau F, Schymkowitz J.
Nucleic Acids Res. 2008 Jan;36(Database issue):D825-9.

Allele-specific targeting of microRNAs to HLA-G and risk of asthma.
Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C.
Am J Hum Genet. 2007 Oct;81(4):829-34.

The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding.
Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS.
J Biol Chem. 2007 Aug 17;282(33):24262-9.

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.
Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR.
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13513-8.

Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a
mechanism for functional single-nucleotide polymorphisms related to phenotypes.
Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE.
Am J Hum Genet. 2007 Aug;81(2):405-13.

A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male
subjects.
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H.
Dig Dis Sci. 2007 Jul;52(7):1691-7.

Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease.
Georges M, Coppieters W, Charlier C.
Curr Opin Genet Dev. 2007 Jun;17(3):166-76.

Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.
Duan R, Pak C, Jin P.
Hum Mol Genet. 2007 May 1;16(9):1124-31.

Human polymorphism at microRNAs and microRNA target sites.
Saunders MA, Liang H, Li WH.
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3300-5.

PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits.
Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y.
Nucleic Acids Res. 2007 Jan;35(Database issue):D51-4.

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.
Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, Wang E, Wu M, Shen SH.
Nucleic Acids Res. 2007;35(13):4535-41.

Natural selection on human microRNA binding sites inferred from SNP data.
Chen K, Rajewsky N.
Nat Genet. 2006 Dec;38(12):1452-6.

RDMAS: a web server for RNA deleterious mutation analysis.
Shu W, Bo X, Liu R, Zhao D, Zheng Z, Wang S.
BMC Bioinformatics. 2006 Sep 6;7:404.

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep.
Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F,
Milenkovic D, Tobin J, Charlier C, Georges M.
Nat Genet. 2006 Jul;38(7):813-8.

Overgrowth caused by misexpression of a microRNA with dispensable wild-type function.
Nairz K, Rottig C, Rintelen F, Zdobnov E, Moser M, Hafen E.
Dev Biol. 2006 Mar 15;291(2):314-24.

A microdeletion in Xp11.3 accounts for co-segregation of retinitis pigmentosa and mental retardation in a large kindred.
Zhang L, Wang T, Wright AF, Suri M, Schwartz CE, Stevenson RE, Valle D.
Am J Med Genet A. 2006 Feb 15;140(4):349-57.

Polymorphic microRNA-target interactions: a novel source of phenotypic variation.
Georges M, Clop A, Marcq F, Takeda H, Pirottin D, Hiard S, Tordoir X, Caiment F, Meish F, Bibe B, Bouix J, Elsen JM, Eychenne F,
Laville E, Larzul C, Milenkovic D, Tobin J, Charlier AC.
Cold Spring Harb Symp Quant Biol. 2006;71:343-50.

Sequence variants in SLITRK1 are associated with Tourette's syndrome.
Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR,
Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LS 4th, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP,
Sestan N, State MW.
Science. 2005 Oct 14;310(5746):317-20.

Regulatory mutations of mir-48, a C. elegans let-7 family MicroRNA, cause developmental timing defects.
Li M, Jones-Rhoades MW, Lau NC, Bartel DP, Rougvie AE.
Dev Cell. 2005 Sep;9(3):415-22.

Polymorphisms in human pre-miRNAs.
Iwai N, Naraba H.
Biochem Biophys Res Commun. 2005 Jun 17;331(4):1439-44.